Arlette Laurien Bruijstens

12PUBLICATIONS
39CO-AUTHORS
AutoimmunityInfant and child healthMedical infection agents (incl. prions)Molecular targetsPaediatrics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 26, 2026
De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD.

|Aug 03, 2026
Update on the Incidence of Paediatric Multiple Sclerosis, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Other Acquired Demyelinating Syndromes in the Netherlands, 2017-2025, Including the COVID-19 Pandemic.

|Mar 18, 2025
Strong association with remote EBV infection in children with MS as opposed to other acquired demyelinating disorders.

Sandy Molenaar, Sandra Scherbeijn, Arlette Bruijstens

|Dec 21, 2024
De-escalating and discontinuing disease-modifying therapies in multiple sclerosis.

Géraldine Androdias, Jan D Lünemann, Elisabeth Maillart

|Mar 06, 2024
MOG Antibodies Restricted to CSF in Children With Inflammatory CNS Disorders.

Gemma Olivé-Cirera, Arlette L Bruijstens, Elianet G Fonseca

|May 12, 2023
Comparison of acute flaccid myelitis and transverse myelitis in children and evaluation of diagnostic criteria.

Jelte Helfferich, Arlette L Bruijstens, Marjolein Knoester

Pageof 2

Frequent Collaborators

5 joint publications

Rinze Frederik Neuteboom

3 joint publications

Sandy Molenaar

2 joint publications

Michiel Simon Jan Buijze

2 joint publications

Joost Smolders